Cargando…

A Novel Microfiber Wipe for Delivery of Active Substances to Human Skin: Clinical Proof of Concept

A novel technology for the delivery of active substances to the skin based on microfibers loaded with dried active substances was developed. The objective of this work was to demonstrate deposition of the active substances on the skin including concurrent cleansing properties of the wipe. As model a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaegi, Martin, Adlhart, Christian, Lehmann, Markus, Risch, Marius, Wessling, Werner, Klaffenbach, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697972/
https://www.ncbi.nlm.nih.gov/pubmed/33212837
http://dx.doi.org/10.3390/polym12112715
_version_ 1783615721849225216
author Kaegi, Martin
Adlhart, Christian
Lehmann, Markus
Risch, Marius
Wessling, Werner
Klaffenbach, Peter
author_facet Kaegi, Martin
Adlhart, Christian
Lehmann, Markus
Risch, Marius
Wessling, Werner
Klaffenbach, Peter
author_sort Kaegi, Martin
collection PubMed
description A novel technology for the delivery of active substances to the skin based on microfibers loaded with dried active substances was developed. The objective of this work was to demonstrate deposition of the active substances on the skin including concurrent cleansing properties of the wipe. As model active substance to measure deposition capacity Niacinamide was used and as parameter to measure cleansing capacities of the wipe squalene uptake was measured. Wipes loaded with niacinamide were used in the face and the forearm of 25 subjects. By means of Raman spectrometry the deposited niacinamide was analyzed before and after application. Wipes used on the face were analyzed for squalene to assess skin cleansing properties and for residual niacinamide. Forearm analysis including placebo and verum on left and right arm respectively was performed to rule out changes of the skin through application of the tissue. Measured amounts of niacinamide from face application demonstrate statistically significant results in the study population. Analysis of the wipes used show a liberation of 28.3% of niacinamide from the wipes and an uptake of 1.7 mg squalene per wipe. Results from forearm application show statistically significant differences (p < 0.05) between placebo and active for the complete study population. Sub group analyses are significant for both gender and ethnicity for face and forearm analysis respectively. Results clearly demonstrate deposition of niacinamide on the skin and the cleansing properties of the wipe. The institutional review board approved this prospective study.
format Online
Article
Text
id pubmed-7697972
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76979722020-11-29 A Novel Microfiber Wipe for Delivery of Active Substances to Human Skin: Clinical Proof of Concept Kaegi, Martin Adlhart, Christian Lehmann, Markus Risch, Marius Wessling, Werner Klaffenbach, Peter Polymers (Basel) Article A novel technology for the delivery of active substances to the skin based on microfibers loaded with dried active substances was developed. The objective of this work was to demonstrate deposition of the active substances on the skin including concurrent cleansing properties of the wipe. As model active substance to measure deposition capacity Niacinamide was used and as parameter to measure cleansing capacities of the wipe squalene uptake was measured. Wipes loaded with niacinamide were used in the face and the forearm of 25 subjects. By means of Raman spectrometry the deposited niacinamide was analyzed before and after application. Wipes used on the face were analyzed for squalene to assess skin cleansing properties and for residual niacinamide. Forearm analysis including placebo and verum on left and right arm respectively was performed to rule out changes of the skin through application of the tissue. Measured amounts of niacinamide from face application demonstrate statistically significant results in the study population. Analysis of the wipes used show a liberation of 28.3% of niacinamide from the wipes and an uptake of 1.7 mg squalene per wipe. Results from forearm application show statistically significant differences (p < 0.05) between placebo and active for the complete study population. Sub group analyses are significant for both gender and ethnicity for face and forearm analysis respectively. Results clearly demonstrate deposition of niacinamide on the skin and the cleansing properties of the wipe. The institutional review board approved this prospective study. MDPI 2020-11-17 /pmc/articles/PMC7697972/ /pubmed/33212837 http://dx.doi.org/10.3390/polym12112715 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kaegi, Martin
Adlhart, Christian
Lehmann, Markus
Risch, Marius
Wessling, Werner
Klaffenbach, Peter
A Novel Microfiber Wipe for Delivery of Active Substances to Human Skin: Clinical Proof of Concept
title A Novel Microfiber Wipe for Delivery of Active Substances to Human Skin: Clinical Proof of Concept
title_full A Novel Microfiber Wipe for Delivery of Active Substances to Human Skin: Clinical Proof of Concept
title_fullStr A Novel Microfiber Wipe for Delivery of Active Substances to Human Skin: Clinical Proof of Concept
title_full_unstemmed A Novel Microfiber Wipe for Delivery of Active Substances to Human Skin: Clinical Proof of Concept
title_short A Novel Microfiber Wipe for Delivery of Active Substances to Human Skin: Clinical Proof of Concept
title_sort novel microfiber wipe for delivery of active substances to human skin: clinical proof of concept
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697972/
https://www.ncbi.nlm.nih.gov/pubmed/33212837
http://dx.doi.org/10.3390/polym12112715
work_keys_str_mv AT kaegimartin anovelmicrofiberwipefordeliveryofactivesubstancestohumanskinclinicalproofofconcept
AT adlhartchristian anovelmicrofiberwipefordeliveryofactivesubstancestohumanskinclinicalproofofconcept
AT lehmannmarkus anovelmicrofiberwipefordeliveryofactivesubstancestohumanskinclinicalproofofconcept
AT rischmarius anovelmicrofiberwipefordeliveryofactivesubstancestohumanskinclinicalproofofconcept
AT wesslingwerner anovelmicrofiberwipefordeliveryofactivesubstancestohumanskinclinicalproofofconcept
AT klaffenbachpeter anovelmicrofiberwipefordeliveryofactivesubstancestohumanskinclinicalproofofconcept
AT kaegimartin novelmicrofiberwipefordeliveryofactivesubstancestohumanskinclinicalproofofconcept
AT adlhartchristian novelmicrofiberwipefordeliveryofactivesubstancestohumanskinclinicalproofofconcept
AT lehmannmarkus novelmicrofiberwipefordeliveryofactivesubstancestohumanskinclinicalproofofconcept
AT rischmarius novelmicrofiberwipefordeliveryofactivesubstancestohumanskinclinicalproofofconcept
AT wesslingwerner novelmicrofiberwipefordeliveryofactivesubstancestohumanskinclinicalproofofconcept
AT klaffenbachpeter novelmicrofiberwipefordeliveryofactivesubstancestohumanskinclinicalproofofconcept